CVS Caremark Corp. (NYSE:CVS) EVP Helena Foulkes sold 53,546 shares of CVS Caremark Corp. stock on the open market in a transaction dated Friday, September 13th. The stock was sold at an average price of $60.00, for a total transaction of $3,212,760.00. Following the completion of the transaction, the executive vice president now directly owns 7,897 shares of the company’s stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Cowen and Company initiated coverage on shares of CVS Caremark Corp. (NYSE:CVS) in a research note to investors on Friday. They set a “market perform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark Corp. (NYSE:CVS) in a research note to investors on Wednesday, August 28th. They now have a $61.00 price target on the stock. Finally, analysts at Barclays Capital raised their price target on shares of CVS Caremark Corp. (NYSE:CVS) from $67.00 to $69.00 in a research note to investors on Thursday, August 8th.
Six analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $62.89.
Shares of CVS Caremark Corp. (NYSE:CVS) traded up 0.66% during mid-day trading on Friday, hitting $59.90. 3,500,006 shares of the company’s stock traded hands. CVS Caremark Corp. has a 52-week low of $44.33 and a 52-week high of $62.36. The stock has a 50-day moving average of $59.45 and a 200-day moving average of $57.77. The company has a market cap of $73.497 billion and a price-to-earnings ratio of 17.66.
CVS Caremark Corp. (NYSE:CVS) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. The company had revenue of $31.25 billion for the quarter, compared to the consensus estimate of $31.13 billion. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, analysts predict that CVS Caremark Corp. will post $3.96 earnings per share for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.